Validated prognostic, predictive, and toxicity markers should help cancer treatment move from the current trial-and-error approach to more personalized treatment.
No takes yet. Share an insight, caveat, or question.
Duffy et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: